Ge, S., Shrestha, B., Paul, D., Keating, C., Cone, R., Guglielmotti, A., & Pachter, J. S. (2012). The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis. BioMed Central.

Ge, Shujun, Bandana Shrestha, Debayon Paul, Carolyn Keating, Robert Cone, Angelo Guglielmotti, a Joel S. Pachter. The CCL2 Synthesis Inhibitor Bindarit Targets Cells of the Neurovascular Unit, and Suppresses Experimental Autoimmune Encephalomyelitis. BioMed Central, 2012.

Ge, Shujun, et al. The CCL2 Synthesis Inhibitor Bindarit Targets Cells of the Neurovascular Unit, and Suppresses Experimental Autoimmune Encephalomyelitis. BioMed Central, 2012.